00:01
In this lecture,
we're going to talk
about human subjects research.
00:04
So now we're going
to take the concepts
of being responsible
clinical researcher,
and really think about
the human subjects
who are involved
in that research.
00:12
Have something called
the translational pathway.
00:15
So we start from basic sciences
all the way through
clinical research,
and then ultimately
to public health,
various ways that
we might interact
with a human participant
in conducting research.
00:29
So first,
there might be basic research.
00:31
So this is scientific
exploration,
that is trying to reveal
fundamental mechanisms of biology,
understand how disease works,
behavior works,
every stage of the
translational research that we
think about is going to
rely on basic research.
00:48
And it also helps to
inform that basic research
or otherwise known
as bench research.
00:54
There might also be in
the translational pathway,
something called
pre-clinical research.
00:58
So now we're moving
from the bench and
getting closer to thinking
about human beings.
01:04
So in pre-clinical research,
we're connecting the
basic sciences of disease
with now human medicine.
01:11
And during this stage,
scientists are developing
model interventions to
further understand the basis of
a disease or disorder and
finding out ways to treat it.
01:21
So the ways that they
might consider testing
or carrying out
pre-clinical research
might be use of cell
or animal models.
01:29
So that might be an example of
how it sort of links
to human beings.
01:33
There might be actual
use of human samples,
or animal tissues
to try to simulate
what's happening
in the human body.
01:41
Or there might actually be
computer-assisted simulation,
where it's, you know, how would
this drug work in a computer model?
The device or diagnostic test,
how would that work,
if it were in, you know,
in a living system?
Then we move into the translational
pathway for clinical research.
02:00
And that's where we're going
to spend the bulk of our time,
but clinical research
includes where you're trying
to better understand
the disease in humans,
and now relate that knowledge
to findings that you've gotten
from the pre-clinical work
in the cell or animal models.
02:16
So you're either going to
test or refine new technologies
and see how that's
working in human beings.
02:22
You're going to test
interventions to see
how safe and effective
they are for both people
with the disease and
people without a disease.
02:30
You might engage in
behavioral observational studies
that would also be
part of clinical research.
02:36
And then also,
the actual health services
system itself might be research.
02:41
So what are the outcomes of
health sciences or health research?
And how does it work
in the clinical realm?
So the goal,
when we think about clinical research
often is to have clinical
trials that we're going to obtain
data to support the
approval of any kind of new
intervention whether
it's a drug or a device,
you need to generate
the knowledge to get
ultimate approval
from that to then make it
available for people
with a particular disease.
03:14
After you've done
clinical research,
the next step in the pathway
is clinical implementation.
03:20
So here,
you might be doing research,
where it's say,
adaption of the intervention,
you've now demonstrated it's
useful in the research environment,
but you now want
to move it into routine
clinical care for the
general population.
03:33
So there might be things
like cost effectiveness studies
to see how does this
actually work in the real world.
03:40
So this stage includes
implementation research,
where you're evaluating
the results of the clinical trials,
trying to identify any new
clinical questions or gaps.
03:48
And, you know,
use that to inform,
go back to either the
drawing board with
preclinical research
or clinical research,
figure out where
there are gaps in care,
and then trying to
implement new processes.
04:01
And then lastly,
in the translational pathway
is going to be public
health research.
04:05
So here,
researchers are studying
health outcomes of a population.
04:09
So at that level,
you're trying to determine
what the effects
of the disease are,
what are the efforts to prevent,
diagnose,
or treat the disease
within the public.
04:19
This is going to help guide
scientists working to assess
the effects of current
interventions at a population level,
and hopefully to
develop new strategies
that are going to
work in the community.
04:32
It may include
epidemiologic research,
so trying to spot patterns,
figure out causes and ways
to control diseases
in certain populations
may also be a means
of identifying risk factors,
and other things that might
be more protective factors
when you're concerned
about particular diseases.
04:52
So that's the whole
translational pathway.
04:54
I'm going to focus
more on clinical trials.
04:57
So these are research
studies that assign
one are more interventions
to human subjects
in order to determine
the effect of that
intervention on
health-related outcomes.
05:08
And those could be both
biomedical or behavioral.
05:11
So a person has a
particular condition,
you're creating an intervention
to try to help with that condition.
05:18
So investigational
interventions might include
things like new therapies
or new medicines.
05:24
It might be psychotherapy.
05:26
It might be new
surgical techniques.
05:29
It might be new or
innovative medical devices.
05:33
It might be different ways
of performing a procedure.
05:36
So different techniques,
anything that you need to
study this innovation to
see if it's going to work.
05:43
And often to compare it to
what's already in existence,
what the standard of care is.
05:51
So all of those, you know,
in a clinical trial,
or any point in
the translational
pathway may involve
a human participants.
05:59
So we have to have
considerations of how to protect
a research participant if
they are engaged in research.
06:07
So there's some
core ethical principles
we think about in
human subjects research.
06:12
There's something
the United States
called the Belmont Report,
written in 1979.
06:17
This was a means
of sort of saying,
these are our
core principles that
all of researchers should
consider if they are going
to work with human
beings as research subjects.
06:29
It's going to be very
similar to those that recall
our previous lectures
on clinical ethics,
we talked about principlism
and the sort of the
core principles of thinking
about clinical medicine.
06:43
Here for clinical research,
there's going to be
a lot of overlap with
those same principles.
06:48
So the three
principles are respect
for persons,
beneficence and justice.
06:54
And the way those were
typically going to be exemplified.
06:58
So respect for
persons is the duty to
obtain voluntary
informed consent.
07:03
So making sure that
the research participant
is voluntarily entering
into the research,
they've been given adequate
information about what
the research is about,
and why they are participating.
07:14
And then they ultimately
consent to being a participant.
07:18
Beneficience, the flip side
of that is nonmaleficence,
if you recall from our
clinical medicine lecture.
07:25
So beneficience is doing good.
07:27
So we want to make sure
that the benefits outweigh
the risks of being a
research participant.
07:33
And that if we envision
that there are any risks
that they are minimized
as much as possible
in conducting that
clinical research.
07:39
And then the last principle in
human subject research is justice.
07:43
So making sure
there's a fair distribution
of the benefits and
the burdens of research.
07:48
And, you know,
in the Belmont Report,
this was written at a time
where there was concerns
about vulnerable populations
being research participants,
there's a higher need
to think about protecting
those that are vulnerable,
making sure they're
not exploited as
research participants.